Neurologic Complications of Checkpoint Inhibitors

    loading  Checking for direct PDF access through Ovid

Abstract

Anti-programmed death 1 antibodies (checkpoint inhibitors) have become a mainstay in the treatment of many types of cancers, and now are known to cause frequent neuromuscular adverse effects that can cause severe disability or death if not recognized or treated promptly.

Related Topics

    loading  Loading Related Articles